Chemotaxins C5a and fMLP induce release of calprotectin (leucocyte L1 protein) from polymorphonuclear cells in vitro.
暂无分享,去创建一个
[1] E. Fosse,et al. Both plasma- and leukocyte-associated C5a are essential for assessment of C5a generation in vivo. , 1997, The Annals of thoracic surgery.
[2] M. Fagerhol. Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein? , 1996, Clinical molecular pathology.
[3] P. Allavena,et al. Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. , 1995, Journal of immunology.
[4] B. Dunn,et al. Antimicrobial activity of calprotectin isolated from human empyema fluid supernatants. , 1995, Clinical immunology and immunopathology.
[5] W. Parks,et al. Cellular expression of the C5a anaphylatoxin receptor (C5aR): demonstration of C5aR on nonmyeloid cells of the liver and lung. , 1995, Journal of immunology.
[6] W. S. Thomas,et al. Uptake of C5a by polymorphonuclear leukocytes (PMNs) after focal cerebral ischemia. I. Effect of tirilazad mesylate intervention on C5a uptake by PMNs. , 1994, Immunopharmacology.
[7] T. Hugli,et al. Induction of interleukin-8 synthesis from monocytes by human C5a anaphylatoxin. , 1994, The American journal of pathology.
[8] E. Prossnitz,et al. Signal transducing properties of the N-formyl peptide receptor expressed in undifferentiated HL60 cells. , 1993, Journal of immunology.
[9] E. Fosse,et al. Calprotectin and complement activation during major operations with or without cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.
[10] R. Lehrer,et al. In vitro Antimicrobial Activity of the Human Neutrophil Cytosolic S-100 Protein Complex, Calprotectin, Against Capnocytophaga sputigena , 1993, Journal of dental research.
[11] M. Fagerhol,et al. Levels of calprotectin (leukocyte L1 protein) during apheresis. , 1992, Scandinavian journal of clinical and laboratory investigation.
[12] A. Røseth,et al. Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. , 1992, Scandinavian journal of gastroenterology.
[13] K. Bergh,et al. Production of monoclonal antibodies against the human anaphylatoxin C5a des Arg and their application in the neoepitope-specific sandwich-ELISA for the quantification of C5a des Arg in plasma. , 1992, Journal of immunological methods.
[14] P. Sohnle,et al. The zinc-reversible antimicrobial activity of neutrophil lysates and abscess fluid supernatants. , 1991, The Journal of infectious diseases.
[15] P. Garred,et al. Activation of complement during apheresis. , 1991, Clinical and experimental immunology.
[16] C. Gerard,et al. The chemotactic receptor for human C5a anaphylatoxin , 1991, Nature.
[17] E. Lingaas,et al. Antimicrobial actions of calcium binding leucocyte L1 protein, calprotectin , 1990, The Lancet.
[18] M. Fagerhol,et al. A longitudinal study of the leukocyte protein L1 as an indicator of disease activity in patients with rheumatoid arthritis. , 1989, The Journal of rheumatology.
[19] P. Garred,et al. Effect of time, temperature and anticoagulants on in vitro complement activation: consequences for collection and preservation of samples to be examined for complement activation. , 1988, Clinical and experimental immunology.
[20] D. Jones,et al. Mac 387 antibody and detection of formalin resistant myelomonocytic L1 antigen. , 1988, Journal of clinical pathology.
[21] W. Marasco,et al. Characterization of the plasma membrane bound GTPase from rabbit neutrophils. I. Evidence for an Ni-like protein coupled to the formyl peptide, C5a, and leukotriene B4 chemotaxis receptors. , 1986, Journal of immunology.
[22] P. Brandtzaeg,et al. Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. , 1985, American journal of clinical pathology.
[23] T. Kurucsev,et al. Vibronic exciton interactions. Resolution and interpretation of the temperature-dependent circular dichroism and absorption spectra of ApA and of dApdA. , 1984, European journal of biochemistry.
[24] R. Snyderman,et al. Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. , 1983, The Journal of clinical investigation.
[25] I. Dale,et al. Purification and partial characterization of a highly immunogenic human leukocyte protein, the L1 antigen. , 1983, European journal of biochemistry.
[26] C. Galanos,et al. Granulocyte activation by endotoxin. I. Correlation between adherence and other granulocyte functions, and role of endotoxin structure on biologic activity. , 1983, Journal of immunology.
[27] G. Duff,et al. The inhibitory effect of polymyxin B on endotoxin-induced endogenous pyrogen production. , 1982, Journal of immunological methods.
[28] A. Day,et al. Synthesis of several chemotactic peptide antagonists , 1980, Peptides.
[29] P. Henson,et al. Neutrophil chemotaxis in response to surface-bound C5A. , 1980, Experimental cell research.
[30] P. Cuatrecasas,et al. Receptor-mediated uptake and degradation of 125I-chemotactic peptide by human neutrophils. , 1979, The Journal of biological chemistry.
[31] T. Hugli,et al. Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes. , 1978, Proceedings of the National Academy of Sciences of the United States of America.
[32] P. Henson,et al. The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness. , 1974, Journal of immunology.
[33] J. Levin,et al. THE ROLE OF ENDOTOXIN IN THE EXTRACELLULAR COAGULATION OF LIMULUS BLOOD. , 1964, Bulletin of the Johns Hopkins Hospital.
[34] P. Mowinckel,et al. The L1 protein as a new indicator of inflammatory activity in patients with juvenile rheumatoid arthritis. , 1991, The Journal of rheumatology.
[35] J. Bakken,et al. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. , 1984, Scandinavian journal of clinical and laboratory investigation.
[36] D. Chenoweth,et al. The C5a receptor of neutrophils and macrophages. , 1983, Agents and actions. Supplements.
[37] Chenoweth De,et al. The C5a receptor of neutrophils and macrophages. , 1983 .
[38] W. Vogt,et al. Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides. , 1980, International archives of allergy and applied immunology.
[39] A. Bøyum,et al. Isolation of mononuclear cells and granulocytes from human blood. , 1968 .